Kratz Christian P, Emerling Brooke M, Bonifas Jeannette, Wang Winfred, Green Eric D, Le Beau Michelle M, Shannon Kevin M
Department of Pediatrics, University of California, San Francisco 94143, USA.
Blood. 2002 Jan 1;99(1):372-4. doi: 10.1182/blood.v99.1.372.
PIK3CG, which encodes the catalytic subunit p110 gamma of phosphoinositide 3-OH-kinase-gamma (PI3K gamma), has been assigned to chromosome band 7q22, a region that is frequently deleted in myeloid malignancies. PI3K gamma-mutant mice have hematologic defects and are predisposed to colon cancer. On the basis of these data, PIK3CG was evaluated as a candidate myeloid tumor suppressor gene (TSG). PIK3CG was mapped by fluorescence in situ hybridization adjacent and telomeric to a commonly deleted segment defined previously in myeloid leukemias with breakpoints within 7q22. PIK3CG contains 10 exons and spans approximately 37 kilobases of genomic DNA. Forty leukemias with monosomy 7 or a del(7q) were screened for PIK3CG mutations. Two patients had missense variations affecting residue 859 in the N-terminal catalytic domain of the protein. This allele was also detected in unaffected parents and in 1 of 60 control alleles; it probably represents a polymorphism. PIK3CG is unlikely to act as a recessive TSG in myeloid leukemias with monosomy 7.
PIK3CG编码磷酸肌醇3-羟基激酶γ(PI3Kγ)的催化亚基p110γ,已定位于7q22染色体带,该区域在髓系恶性肿瘤中经常发生缺失。PI3Kγ突变小鼠有血液学缺陷,且易患结肠癌。基于这些数据,PIK3CG被评估为候选髓系肿瘤抑制基因(TSG)。通过荧光原位杂交将PIK3CG定位在先前在髓系白血病中定义的一个常见缺失片段附近且位于其端粒侧,该片段的断点在7q22内。PIK3CG包含10个外显子,跨越约37千碱基的基因组DNA。对40例7号染色体单体或7q缺失的白血病患者进行了PIK3CG突变筛查。两名患者有影响该蛋白N端催化结构域中859位残基的错义变异。该等位基因也在未受影响的父母及60个对照等位基因中的1个中检测到;它可能代表一种多态性。在7号染色体单体的髓系白血病中,PIK3CG不太可能作为隐性肿瘤抑制基因发挥作用。